<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36555496</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass Spectrometry.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">15853</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232415853</ELocationID><Abstract><AbstractText>Damage induced by oxidative stress is a key driver of the selective motor neuron death in amyotrophic lateral sclerosis (ALS). Mitochondria are among the main producers of ROS, but they also suffer particularly from their harmful effects. Voltage-dependent anion-selective channels (VDACs) are the most represented proteins of the outer mitochondrial membrane where they form pores controlling the permeation of metabolites responsible for mitochondrial functions. For these reasons, VDACs contribute to mitochondrial quality control and the entire energy metabolism of the cell. In this work we assessed in an ALS cell model whether disease-related oxidative stress induces post-translational modifications (PTMs) in VDAC3, a member of the VDAC family of outer mitochondrial membrane channel proteins, known for its role in redox signaling. At this end, protein samples enriched in VDACs were prepared from mitochondria of an ALS model cell line, NSC34 expressing human SOD1G93A, and analyzed by nUHPLC/High-Resolution nESI-MS/MS. Specific over-oxidation, deamidation, succination events were found in VDAC3 from ALS-related NSC34-SOD1G93A but not in non-ALS cell lines. Additionally, we report evidence that some PTMs may affect VDAC3 functionality. In particular, deamidation of Asn215 alone alters single channel behavior in artificial membranes. Overall, our results suggest modifications of VDAC3 that can impact its protective role against ROS, which is particularly important in the ALS context. Data are available via ProteomeXchange with identifier PXD036728.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pittal&#xe0;</LastName><ForeName>Maria Gaetana Giovanna</ForeName><Initials>MGG</Initials><AffiliationInfo><Affiliation>Organic Mass Spectrometry Laboratory, Department of Chemical Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reina</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nibali</LastName><ForeName>Stefano Conti</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cucina</LastName><ForeName>Annamaria</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3337-5995</Identifier><AffiliationInfo><Affiliation>Organic Mass Spectrometry Laboratory, Department of Chemical Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cubisino</LastName><ForeName>Salvatore Antonio Maria</ForeName><Initials>SAM</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunsolo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2349-5494</Identifier><AffiliationInfo><Affiliation>Organic Mass Spectrometry Laboratory, Department of Chemical Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amodeo</LastName><ForeName>Giuseppe Federico</ForeName><Initials>GF</Initials><Identifier Source="ORCID">0000-0002-5316-2770</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foti</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4007-6582</Identifier><AffiliationInfo><Affiliation>Organic Mass Spectrometry Laboratory, Department of Chemical Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Pinto</LastName><ForeName>Vito</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5513-2906</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saletti</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1990-6764</Identifier><AffiliationInfo><Affiliation>Organic Mass Spectrometry Laboratory, Department of Chemical Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5745-9846</Identifier><AffiliationInfo><Affiliation>Department of Biological, Geological and Environmental Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PEPSLA POC 01_00054</GrantID><Agency>MIUR PNR "Proof of Concept 2018" grant</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050994">Voltage-Dependent Anion Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494768">VDAC3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033681">Mitochondrial Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="Y">Tandem Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050994" MajorTopicYN="N">Voltage-Dependent Anion Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033681" MajorTopicYN="N">Mitochondrial Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">deamidation</Keyword><Keyword MajorTopicYN="N">high-resolution mass spectrometry</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">over-oxidation</Keyword><Keyword MajorTopicYN="N">post-translational modifications</Keyword><Keyword MajorTopicYN="N">succination</Keyword><Keyword MajorTopicYN="N">voltage dependent anion channel</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36555496</ArticleId><ArticleId IdType="pmc">PMC9784795</ArticleId><ArticleId IdType="doi">10.3390/ijms232415853</ArticleId><ArticleId IdType="pii">ijms232415853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.J., McKeown S.R., Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanghai N., Tranmer G.K. Hydrogen Peroxide and Amyotrophic Lateral Sclerosis: From Biochemistry to Pathophysiology. Antioxidants. 2021;11:52. doi: 10.3390/antiox11010052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010052</ArticleId><ArticleId IdType="pmc">PMC8773294</ArticleId><ArticleId IdType="pubmed">35052556</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Borchelt D.R. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol. Neurodegener. 2011;6:77. doi: 10.1186/1750-1326-6-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-77</ArticleId><ArticleId IdType="pmc">PMC3248846</ArticleId><ArticleId IdType="pubmed">22094223</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondola P., Damiano S., Sassa A., Santillo M. The Cu, Zn Superoxide Dismutase: Not Only a Dismutase Enzyme. Front. Physiol. 2016;7:594. doi: 10.3389/fphys.2016.00594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00594</ArticleId><ArticleId IdType="pmc">PMC5126113</ArticleId><ArticleId IdType="pubmed">27965593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Lu Y., Qi F., Su Q., Wang L., You C., Che F., Yu J. Effect of the human SOD1-G93A gene on the nrf2/ARE signaling pathway in NSC-34 cells. Mol. Med. Rep. 2014;9:2453&#x2013;2458. doi: 10.3892/mmr.2014.2087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2087</ArticleId><ArticleId IdType="pubmed">24682253</ArticleId></ArticleIdList></Reference><Reference><Citation>Marden J.J., Harraz M.M., Williams A.J., Nelson K., Luo M., Paulson H., Engelhardt J.F. Redox modifier genes in amyotrophic lateral sclerosis in mice. J. Clin. Investig. 2007;117:2913&#x2013;2919. doi: 10.1172/JCI31265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI31265</ArticleId><ArticleId IdType="pmc">PMC1974865</ArticleId><ArticleId IdType="pubmed">17853944</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shteinfer-Kuzmine A., Argueti S., Gupta R., Shvil N., Abu-Hamad S., Gropper Y., Hoeber J., Magr&#xec; A., Messina A., Kozlova E.N., et al. A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS. Front. Cell. Neurosci. 2019;13:346. doi: 10.3389/fncel.2019.00346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00346</ArticleId><ArticleId IdType="pmc">PMC6702328</ArticleId><ArticleId IdType="pubmed">31474832</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., De Pinto V., Zweckstetter M., Raviv Z., Keinan N., Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Asp. Med. 2010;31:227&#x2013;285. doi: 10.1016/j.mam.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2010.03.002</ArticleId><ArticleId IdType="pubmed">20346371</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri A., Messina A. Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules. Curr. Med. Chem. 2017;24:4470&#x2013;4487. doi: 10.2174/0929867324666170601073920.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867324666170601073920</ArticleId><ArticleId IdType="pubmed">28571556</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V., Ben-Hail D. VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion. 2012;12:24&#x2013;34. doi: 10.1016/j.mito.2011.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2011.04.001</ArticleId><ArticleId IdType="pubmed">21530686</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina S., Guarino F., Magr&#xec; A., De Pinto V. VDAC3 As a Potential Marker of Mitochondrial Status Is Involved in Cancer and Pathology. Front. Oncol. 2016;6:264. doi: 10.3389/fonc.2016.00264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2016.00264</ArticleId><ArticleId IdType="pmc">PMC5179545</ArticleId><ArticleId IdType="pubmed">28066720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.-C., Peterson S.E., Loring J.F. Protein post-translational modifications and regulation of pluripotency in human stem cells. Cell Res. 2013;24:143&#x2013;160. doi: 10.1038/cr.2013.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.151</ArticleId><ArticleId IdType="pmc">PMC3915910</ArticleId><ArticleId IdType="pubmed">24217768</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan G., Walther D. The Roles of Post-translational Modifications in the Context of Protein Interaction Networks. PLoS Comput. Biol. 2015;11:e1004049. doi: 10.1371/journal.pcbi.1004049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004049</ArticleId><ArticleId IdType="pmc">PMC4333291</ArticleId><ArticleId IdType="pubmed">25692714</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina S., Pittal&#xe0; M.G.G., Guarino F., Messina A., De Pinto V., Foti S., Saletti R. Cysteine Oxidations in Mitochondrial Membrane Proteins: The Case of VDAC Isoforms in Mammals. Front. Cell Dev. Biol. 2020;8:397. doi: 10.3389/fcell.2020.00397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00397</ArticleId><ArticleId IdType="pmc">PMC7287182</ArticleId><ArticleId IdType="pubmed">32582695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittal&#xe0; M.G.G., Nibali S.C., Reina S., Cunsolo V., Di Francesco A., De Pinto V., Messina A., Foti S., Saletti R. VDACs Post-Translational Modifications Discovery by Mass Spectrometry: Impact on Their Hub Function. Int. J. Mol. Sci. 2021;22:12833. doi: 10.3390/ijms222312833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222312833</ArticleId><ArticleId IdType="pmc">PMC8657666</ArticleId><ArticleId IdType="pubmed">34884639</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittal&#xe0; M.G.G., Reina S., Cubisino S.A.M., Cucina A., Formicola B., Cunsolo V., Foti S., Saletti R., Messina A. Post-Translational Modification Analysis of VDAC1 in ALS-SOD1 Model Cells Reveals Specific Asparagine and Glutamine Deamidation. Antioxidants. 2020;9:1218. doi: 10.3390/antiox9121218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9121218</ArticleId><ArticleId IdType="pmc">PMC7761621</ArticleId><ArticleId IdType="pubmed">33276691</ArticleId></ArticleIdList></Reference><Reference><Citation>Magr&#xec; A., Reina S., De Pinto V. VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis. Front. Chem. 2018;6:108. doi: 10.3389/fchem.2018.00108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2018.00108</ArticleId><ArticleId IdType="pmc">PMC5897536</ArticleId><ArticleId IdType="pubmed">29682501</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilansky S., Dangoor L., Nakdimon I., Ben-Hail D., Mizrachi D., Shosha-Barmatz V. The Voltage-Dependent Anion Channel 1 mediates amyloid beta toxicity and represents a potential target for Alzheimer&#x2019;s disease theraphy. JBC. 2015;290:30670&#x2013;30683. doi: 10.1074/jbc.M115.691493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.691493</ArticleId><ArticleId IdType="pmc">PMC4692199</ArticleId><ArticleId IdType="pubmed">26542804</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina S., Checchetto V., Saletti R., Gupta A., Chaturvedi D., Guardiani C., Guarino F., Scorciapino M.A., Magr&#xec; A., Foti S., et al. VDAC3 as a sensor of oxidative state of the intermembrane space of mitochondria: The putative role of cysteine residue modifications. Oncotarget. 2016;7:2249&#x2013;2268. doi: 10.18632/oncotarget.6850.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6850</ArticleId><ArticleId IdType="pmc">PMC4823033</ArticleId><ArticleId IdType="pubmed">26760765</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina S., Nibali S.C., Tomasello M.F., Magr&#xec; A., Messina A., De Pinto V. Voltage Dependent Anion Channel 3 (VDAC3) protects mitochondria from oxidative stress. Redox Biol. 2022;51:102264. doi: 10.1016/j.redox.2022.102264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102264</ArticleId><ArticleId IdType="pmc">PMC8857518</ArticleId><ArticleId IdType="pubmed">35180474</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletti R., Reina S., Pittal&#xe0; M.G., Belfiore R., Cunsolo V., Messina A., De Pinto V., Foti S. High resolution mass spectrometry characterization of the oxidation pattern of methionine and cysteine residues in rat liver mitochondria voltage-dependent anion selective channel 3 (VDAC3) Biochim. Biophys. Acta (BBA) Biomembr. 2017;1859:301&#x2013;311. doi: 10.1016/j.bbamem.2016.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2016.12.003</ArticleId><ArticleId IdType="pubmed">27989743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittal&#xe0; M.G.G., Saletti R., Reina S., Cunsolo V., De Pinto V., Foti S. A High Resolution Mass Spectrometry Study Reveals the Potential of Disulfide Formation in Human Mitochondrial Voltage-Dependent Anion Selective Channel Isoforms (hVDACs) Int. J. Mol. Sci. 2020;21:1468. doi: 10.3390/ijms21041468.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041468</ArticleId><ArticleId IdType="pmc">PMC7073118</ArticleId><ArticleId IdType="pubmed">32098132</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Z., Yates N.A., Bakhtiar R. Detection and characterization of methionine oxidation in peptides by collision-induced dissociation and electron capture dissociation. J. Am. Soc. Mass Spectrom. 2003;14:605&#x2013;613. doi: 10.1016/S1044-0305(03)00201-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1044-0305(03)00201-0</ArticleId><ArticleId IdType="pubmed">12781462</ArticleId></ArticleIdList></Reference><Reference><Citation>Cournoyer J.J., Pittman J.L., Ivleva V.B., Fallows E., Waskell L., Costello C.E., O&#x2019;Connor P.B. Deamidation: Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation. Protein Sci. 2005;14:452&#x2013;463. doi: 10.1110/ps.041062905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.041062905</ArticleId><ArticleId IdType="pmc">PMC2253403</ArticleId><ArticleId IdType="pubmed">15659375</ArticleId></ArticleIdList></Reference><Reference><Citation>Jov&#xe9; M., Pradas I., Mota-Martorell N., Cabr&#xe9; R., Ayala V., Ferrer I., Pamplona R. Succination of Protein Thiols in Human Brain Aging. Front. Aging Neurosci. 2020;12:52. doi: 10.3389/fnagi.2020.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.00052</ArticleId><ArticleId IdType="pmc">PMC7068737</ArticleId><ArticleId IdType="pubmed">32210786</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo S., Trojsi F., Salvatore A., Daniele L., Raimo M., Galletti P., Monsurr&#xf2; M.R. Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis. Neurochem. Int. 2013;63:626&#x2013;634. doi: 10.1016/j.neuint.2013.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.09.006</ArticleId><ArticleId IdType="pubmed">24044898</ArticleId></ArticleIdList></Reference><Reference><Citation>Checchetto V., Reina S., Magr&#xec; A., Szabo I., De Pinto V. Recombinant Human Voltage Dependent Anion Selective Channel Isoform 3 (hVDAC3) Forms Pores with a Very Small Conductance. Cell Physiol. Biochem. 2014;34:842&#x2013;853. doi: 10.1159/000363047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000363047</ArticleId><ArticleId IdType="pubmed">25171321</ArticleId></ArticleIdList></Reference><Reference><Citation>Nibali S.C., Di Rosa M.C., Rauh O., Thiel G., Reina S., De Pinto V. Cell-free electrophysiology of human VDACs incorporated into nanodiscs: An improved method. Biophys. Rep. 2021;1:100002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448298</ArticleId><ArticleId IdType="pubmed">34568862</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddy K.A., White M.Y., Cordwell S.J. Functional decorations: Post-translational modifications and heart disease delineated by targeted proteomics. Genome Med. 2013;5:20. doi: 10.1186/gm424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gm424</ArticleId><ArticleId IdType="pmc">PMC3706772</ArticleId><ArticleId IdType="pubmed">23445784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomin T., Schittmayer M., Honeder S., Heininger C., Birner-Gruenberger R. Irreversible oxidative post-translational modifications in heart disease. Expert Rev. Proteom. 2019;16:681&#x2013;693. doi: 10.1080/14789450.2019.1645602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2019.1645602</ArticleId><ArticleId IdType="pmc">PMC6816499</ArticleId><ArticleId IdType="pubmed">31361162</ArticleId></ArticleIdList></Reference><Reference><Citation>Okazaki M., Kurabayashi K., Asanuma M., Saito Y., Dodo K., Sodeoka M. VDAC3 gating is activated by suppression of disulfide-bond formation between the N-terminal region and the bottom of the pore. Biochim. Biophys. Acta. 2015;1848:3188&#x2013;3196. doi: 10.1016/j.bbamem.2015.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2015.09.017</ArticleId><ArticleId IdType="pubmed">26407725</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina A., Reina S., Guarino F., Magr&#xec; A., Tomasello F., Clark R.E., Ramsay R.R., De Pinto V. Live cell interactome of the human voltage dependent anion channel 3 (VDAC3) revealed in HeLa cells by affinity purification tag technique. Mol. BioSyst. 2014;10:2134&#x2013;2145. doi: 10.1039/C4MB00237G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4MB00237G</ArticleId><ArticleId IdType="pubmed">24865465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Bonifacino T., Bartolucci M., Milanese M., Gallia E., Provenzano F., Cortese K., Panfoli I., Bonanno G. Char-acterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2018;55:9220&#x2013;9233. doi: 10.1007/s12035-018-1059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hains P.G., Truscott R.J.W. Age-Dependent Deamidation of Life long Proteins in the Human Lens. Investig. Ophthalmol. Vis. Sci. 2010;51:3107&#x2013;3114. doi: 10.1167/iovs.09-4308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.09-4308</ArticleId><ArticleId IdType="pmc">PMC2891470</ArticleId><ArticleId IdType="pubmed">20053973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooi M.Y.S., Raftery M.J., Truscott R.J.W. Racemization of Two Proteins over Our Lifespan: Deamidation of Asparagine 76 in &#x3b3;S Crystallin Is Greater in Cataract than in Normal Lenses across the Age Range. Investig. Ophthalmol. Vis. Sci. 2012;53:3554&#x2013;3561. doi: 10.1167/iovs.11-9085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.11-9085</ArticleId><ArticleId IdType="pmc">PMC3406884</ArticleId><ArticleId IdType="pubmed">22531704</ArticleId></ArticleIdList></Reference><Reference><Citation>Truscott R.J.W. Are Ancient Proteins Responsible for the Age-Related Decline in Health and Fitness? Rejuvenation Res. 2010;13:83&#x2013;89. doi: 10.1089/rej.2009.0938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/rej.2009.0938</ArticleId><ArticleId IdType="pmc">PMC2883525</ArticleId><ArticleId IdType="pubmed">20230282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner H., Helliger W. Age-dependent deamidation of asparagine residues in proteins. Exp. Gerontol. 2001;36:1551&#x2013;1563. doi: 10.1016/S0531-5565(01)00140-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(01)00140-1</ArticleId><ArticleId IdType="pubmed">11525877</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson N.E., Robinson M.L., Schulze S.E.S., Lai B.T., Gray H.B. Deamidation of&#x3b1;-synuclein. Protein Sci. 2009;18:1766&#x2013;1773. doi: 10.1002/pro.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.183</ArticleId><ArticleId IdType="pmc">PMC2776963</ArticleId><ArticleId IdType="pubmed">19521992</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Watanabe A., Ogawara M., Mori H., Shirasawa T. Isoaspartate Formation and Neurodegeneration in Alzheimer&#x2019;s Disease. Arch. Biochem. Biophys. 2000;381:225&#x2013;234. doi: 10.1006/abbi.2000.1955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.2000.1955</ArticleId><ArticleId IdType="pubmed">11032409</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigneswara V., Cass S., Wayne D., Bolt E.L., Ray D.E., Carter W.G. Molecular Ageing of Alpha- and Beta-Synucleins: Protein Damage and Repair Mechanisms. PLoS ONE. 2013;8:e61442. doi: 10.1371/journal.pone.0061442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061442</ArticleId><ArticleId IdType="pmc">PMC3632608</ArticleId><ArticleId IdType="pubmed">23630590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastrup J., Kastaniegaard K., Asuni A.A., Volbracht C., Stensballe A. Proteomicand Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2020;73:393&#x2013;411. doi: 10.3233/JAD-190652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190652</ArticleId><ArticleId IdType="pubmed">31771055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmarth P.A., Tanner S., Dasari S., Nagalla S.R., Riviere M.A., Bafna V., Pevzner P.A., David L.L. Age-related changes in human crystallins determined from comparative analysis of post-translational modifications in young and aged lens: Does deamidation contribute to crystallin insolubility? J. Proteome Res. 2006;5:2554&#x2013;2566. doi: 10.1021/pr050473a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr050473a</ArticleId><ArticleId IdType="pmc">PMC2536618</ArticleId><ArticleId IdType="pubmed">17022627</ArticleId></ArticleIdList></Reference><Reference><Citation>Catak S., Monard G., Aviyente V., Ruiz-Lo&#xb4;pez M.F. Deamidation of Asparagine Residues: Direct Hydrolysis versus Succinimide-Mediated Deamidation Mechanisms. J. Phys. Chem. 2009;113:1111&#x2013;1120. doi: 10.1021/jp808597v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp808597v</ArticleId><ArticleId IdType="pubmed">19152321</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiger T., Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 1987;262:785&#x2013;794. doi: 10.1016/S0021-9258(19)75855-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)75855-4</ArticleId><ArticleId IdType="pubmed">3805008</ArticleId></ArticleIdList></Reference><Reference><Citation>Reissner K.J., Aswad D.W. Deamidation and isoaspartate formation in proteins: Unwanted alterations or surreptitious signals? Cell Mol. Life Sci. 2003;60:1281&#x2013;1295. doi: 10.1007/s00018-003-2287-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-003-2287-5</ArticleId><ArticleId IdType="pubmed">12943218</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Matsuoka Y., Shirasawa T. Biological Significance of Isoaspartate and Its Repair System. Biol. Pharm. Bull. 2005;28:1590&#x2013;1596. doi: 10.1248/bpb.28.1590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.28.1590</ArticleId><ArticleId IdType="pubmed">16141521</ArticleId></ArticleIdList></Reference><Reference><Citation>Galletti P., De Bonis M.L., Sorrentino A., Raimo M., D&#x2019;Angelo S., Scala I., Andria G., D&#x2019;Aniello A., Ingrosso D., Zappia V. Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down&#x2019;s syndrome. FEBS J. 2007;27:5263&#x2013;5277. doi: 10.1111/j.1742-4658.2007.06048.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2007.06048.x</ArticleId><ArticleId IdType="pubmed">17892495</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderson N.L., Wang Y., Blatnik M., Frizzell N., Walla M.D., Lyons T.J., Alt N., Carson J.A., Nagai R., Thorpe S.R., et al. S-(2-Succinyl)cysteine: A novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch. Biochem. Biophys. 2006;450:1&#x2013;8. doi: 10.1016/j.abb.2006.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2006.03.005</ArticleId><ArticleId IdType="pubmed">16624247</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletti R., Reina S., Pittal&#xe0; M.G., Magr&#xec; A., Cunsolo V., Foti S., De Pinto V. Post-translational modifications of VDAC1 and VDAC2 cysteines from rat liver mitochondria. Biochim. Biophys. Acta Bioenerg. 2018;1859:806&#x2013;816. doi: 10.1016/j.bbabio.2018.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2018.06.007</ArticleId><ArticleId IdType="pubmed">29890122</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan R., Wang J., Cai Z., Li Z., Wang L., Li Y., Xu J., Li D., Yao H., Liu W., et al. Hydrogen sulfide attenuates cigarette smoke-induced airway remodeling by upregulating SIRT1 signaling pathway. Redox Biol. 2020;28:101356. doi: 10.1016/j.redox.2019.101356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101356</ArticleId><ArticleId IdType="pmc">PMC6854091</ArticleId><ArticleId IdType="pubmed">31704583</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkley E.D., Metz T.O., Smith R.D., Baynes J.W., Frizzell N. The succinated proteome. Mass Spectrom. Rev. 2014;32:98&#x2013;109. doi: 10.1002/mas.21382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mas.21382</ArticleId><ArticleId IdType="pmc">PMC4038156</ArticleId><ArticleId IdType="pubmed">24115015</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel A.M., Walla M.D., Faccenda A., Martin S.L., Tanis R.M., Piroli G.G., Adam J., Kantor B., Mutus B., Townsend D.M., et al. Succination of Protein Disulfide Isomerase Links Mitochondrial Stress and Endoplasmic Reticulum Stress in the Adipocyte During Diabetes. Antioxid. Redox Signal. 2017;27:1281&#x2013;1296. doi: 10.1089/ars.2016.6853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2016.6853</ArticleId><ArticleId IdType="pmc">PMC5655420</ArticleId><ArticleId IdType="pubmed">28376661</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroli G.G., Manuel A.M., Walla M.D., Jepson M.J., Brock J.W.C., Rajesh M.P., Tanis R.M., Cotham W.E., Frizzell N. Identification of protein succination as a novel modification of tubulin. Biochem. J. 2014;462:231&#x2013;245. doi: 10.1042/BJ20131581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20131581</ArticleId><ArticleId IdType="pmc">PMC4324573</ArticleId><ArticleId IdType="pubmed">24909641</ArticleId></ArticleIdList></Reference><Reference><Citation>Twelvetrees A.E. The lifecycle of the neuronal microtubule transport machinery. Semin. Cell Dev. Biol. 2020;107:74&#x2013;81. doi: 10.1016/j.semcdb.2020.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.02.008</ArticleId><ArticleId IdType="pubmed">32173271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.D., Rotilio G., Valentine J.S., Carr&#xec; M.T. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. USA. 2006;103:13860&#x2013;13865. doi: 10.1073/pnas.0605814103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605814103</ArticleId><ArticleId IdType="pmc">PMC1557633</ArticleId><ArticleId IdType="pubmed">16945901</ArticleId></ArticleIdList></Reference><Reference><Citation>Magr&#xec; A., Belfiore R., Reina S., Tomasello M.F., Di Rosa M.C., Guarino F., Leggio L., De Pinto V., Messina A. Hexokinase I N-terminal based peptide prevents the VDAC1-SOD1 G93A interaction and re-establishes ALS cell viability. Sci. Rep. 2016;6:34802. doi: 10.1038/srep34802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34802</ArticleId><ArticleId IdType="pmc">PMC5056396</ArticleId><ArticleId IdType="pubmed">27721436</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello R., Messina A., Schiffler B., Benz R., Tasco G., Casadio R., De Pinto V. Functional characterization of a second porin isoform in Drosophila melanogaster&#x2013;DmPorin2 forms voltage-independent cation-selective pores. J. Biol. Chem. 2004;279:25364&#x2013;25373. doi: 10.1074/jbc.M310572200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M310572200</ArticleId><ArticleId IdType="pubmed">15054101</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina S., Magr&#xec; A., Lolicato M., Guarino F., Impellizzeri A., Maier E., Benz R., Ceccarelli M., De Pinto V., Messina A. Deletion of &#x3b2;-strands 9 and 10 converts VDAC1 voltage-dependence in an asymmetrical process. Biochim. Biophys. Acta Bioenerg. 2013;1827:793&#x2013;805. doi: 10.1016/j.bbabio.2013.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2013.03.007</ArticleId><ArticleId IdType="pubmed">23541892</ArticleId></ArticleIdList></Reference><Reference><Citation>Guardiani C., Magr&#xec; A., Karachitos A., Di Rosa M.C., Reina S., Bodrenko I., Messina A., Kmita H., Ceccarelli M., De Pinto V. yVDAC2, the second mitochondrial porin isoform of Saccharomyces cerevisiae. Biochim. Biophys. Acta Bioenerg. 2018;1859:270&#x2013;279. doi: 10.1016/j.bbabio.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2018.01.008</ArticleId><ArticleId IdType="pubmed">29408701</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb B., Sali A. Comparative Protein Structure Modeling Using MODELLER. Curr. Protoc. 2016;54:5&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5031415</ArticleId><ArticleId IdType="pubmed">27322406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>